Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer (Abraxane)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by Columbia University.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Columbia University
ClinicalTrials.gov Identifier:
NCT00583349
First received: December 20, 2007
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)